|
|
Volumn 3, Issue 3, 1998, Pages 143-152
|
|
Management of advanced breast cancer: Defining the role of toremifene
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIESTROGEN;
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
GESTAGEN;
GONADORELIN DERIVATIVE;
HORMONE RECEPTOR;
LIPID;
TAMOXIFEN;
TOREMIFENE;
UNINDEXED DRUG;
ADVANCED CANCER;
ALOPECIA;
BONE MARROW SUPPRESSION;
BONE METABOLISM;
BREAST CANCER;
BREAST METASTASIS;
CANCER PALLIATIVE THERAPY;
CANCER SURGERY;
CAUSE OF DEATH;
CLINICAL TRIAL;
DEEP VEIN THROMBOSIS;
DIARRHEA;
DRUG CARCINOGENICITY;
DRUG EFFICACY;
DRUG TOLERABILITY;
EARLY DIAGNOSIS;
ENDOMETRIUM CANCER;
FAMILY HISTORY;
FATIGUE;
FEMALE;
HEADACHE;
HORMONAL THERAPY;
HOT FLUSH;
HUMAN;
HYPERTENSION;
INCIDENCE;
LIPID BLOOD LEVEL;
MORBIDITY;
MUCOSA INFLAMMATION;
NAUSEA;
OBESITY;
REVIEW;
VAGINA BLEEDING;
VOMITING;
|
|
EID: 0031942808
PISSN: 11738790
EISSN: None
Source Type: Journal
DOI: 10.2165/00115677-199803030-00004 Document Type: Review |
|
Times cited : (1)
|
|
References (1)
|
